Form EFFECT Veraxa Biotech Holding
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 6, 2026 4:00 P.M. |
| Form: | F-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 56% of consumers say paying off short-term debt would take over six months, Achieve survey finds
- Healthcare Management Administrators Appoints Diane Zalewski as CEO
- Agentio Helps Turo Scale Hundreds of Creator Partnerships With a Team of One
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
